uniQure N.V. stock, traded as QURE on NASDAQ, has been the subject of various reports and analyses. Some outlets have noted changes in analyst estimates and forecasts for the company, with some indicating a darker outlook since its latest report. The stock's price has also seen movement, with one report noting a 6.1% increase after an equity raise and FDA backing.